Drug czar nominee withdraws after report he backed Big Pharma opioid bill

President Trump announced Tuesday that Rep. Tom Marino (R-Pa.) has withdrawn his name from consideration for the head of the Office of National Drug Control Policy. "Tom is a fine man and a great congressman," Trump tweeted while sharing the news. On Sunday night, 60 Minutes and The Washington Post reported that Marino had worked for two years to push through a bill promoted and apparently written by the pharmaceutical industry that stripped the Drug Enforcement Administration of its biggest tool to fight prescription opioids entering the black market.